blind randomized placebo

Related by string. * Bed Liner . BLIND . BLIN . Blind : blind placebo controlled . blind eye . Blind Faith . Blind Side / Randomized . randomizing . randomizer : randomized controlled trial . randomized controlled trials . randomized clinical trials . randomized controlled clinical trials / placebos . Placebo . Placebos : placebo controlled clinical trials . randomized placebo controlled . double blind placebo * *

Related by context. Frequent words. (Click for all words.) 85 blind randomized 83 double blind placebo 80 randomized double 80 randomized placebo controlled 79 placebo controlled 76 prospective randomized 76 blind placebo controlled 75 randomized controlled 73 multicenter 71 randomized 70 randomized clinical 68 dose escalation study 65 Phase 2b study 65 Phase IIb trial 65 Phase Ib 64 pivotal Phase III 64 multicenter study 64 Phase 2b 63 Randomized 63 Phase IIb 63 randomized controlled trial 63 Phase 2a clinical 63 Phase 2b trial 63 multiple ascending dose 62 Phase 2b clinical 62 Phase III clinical 62 Phase 1b 61 Phase IIa 61 dose escalation 61 pharmacodynamics 61 pivotal Phase 60 randomized Phase 60 Phase IIa trial 60 safety tolerability 60 Phase IIb clinical 60 mg BID 59 prospective cohort 59 clinical trial 59 Phase III 59 Phase 2a 59 tolerability 59 Phase IIa clinical 58 Phase III pivotal 57 dosing regimens 57 investigational oral 57 pharmacokinetics 57 mg dose 56 randomized clinical trials 56 relapsing remitting multiple sclerosis 55 randomized controlled trials 55 RG# [001] 55 plus ribavirin 55 eculizumab 54 dose regimen 54 ISIS # 54 randomized trials 54 DSMB 54 Efficacy 54 CRx 54 ACTEMRA 54 mg doses 54 TMC# [001] 54 observational study 54 evaluable patients 54 pharmacokinetic profile 54 Phase III clinical trials 53 non inferiority 53 Phase III trials 53 monotherapy 53 pharmacokinetic 53 unblinded 53 rosuvastatin 53 adalimumab 53 SEROQUEL 53 telmisartan 52 lubiprostone 52 confirmatory Phase 3 52 PRX # 52 ofatumumab 52 primary endpoint 52 JANUVIA 52 dosing 52 FOLFOX 52 sunitinib 52 Clinical Study 52 investigational compound 52 etanercept 51 dose limiting toxicities 51 pegylated interferon 51 pharmacodynamic 51 RDEA# 51 mg/m2 51 aliskiren 51 tolerability profile 51 n = 51 laquinimod 51 Phase II 51 atypical antipsychotic 50 tiotropium 50 aripiprazole 50 CYT#

Back to home page